June 19 is World Sickle Cell Day

Globally, more than 300,000 babies are born with sickle cell disease every year. We won't stop until we find a cure.

Donate Now

Learn More


From our first sickle cell disease research grant in 1958, to pioneering the use of hydroxyurea in pediatric sickle cell disease patients, St. Jude has been committed to researching, understanding and improving standards of care for this disease since our very beginning.


Discover the events that set St. Jude apart

Since opening in 1962, St. Jude has been committed to finding a cure for sickle cell disease.

Timeline icon

View Timeline


 How is St. Jude helping to find a cure for sickle cell disease? 

  • St. Jude is enhancing our bone marrow transplantation program to further improve outcomes for children with sickle cell disease. The program will create new clinical trials, improve the entire transplant process and identify ways to decrease transplant-related side effects in children. 

  • St. Jude researchers are exploring a cure for sickle cell disease through innovative gene therapy approaches. Gene therapy treats genetic diseases by giving patients a healthy version of a defective gene. 

  • Today, we are leading the Sickle Cell Clinical Research and Intervention Program (SCCRIP), which will study how sickle cell disease progresses over time, from childhood into adulthood, and how we can improve the quality of life for sickle cell disease patients while we continue to search for cures.

Help more children survive sickle cell disease.

Donate Now


Other ways to take action

stay in touch

Stay in touch

Sign up to receive, via email or text, patient stories, research news and info on other ways to support St. Jude.

Sign Up


Tell everyone you know

Share with loved ones how you’re supporting St. Jude and World Sickle Cell Day, and ask if they would, too.


You might also be interested in: